Thus, the combined application of plumbagin and BAY876 or 6-AN induces synergistic apoptotic effects and overcomes plumbagin resistance in Keap1-mutant NSCLC cells [94]. The gene discussed is KEAP1; the disease is non-small cell lung carcinoma.